Enhanced survival and engraftment of transplanted stem cells using growth factor sequestering hydrogels

Biomaterials

Volumn 47, Issue , 2015, Pages 1-12

  Jha, Amit K ^a,b   Tharp, Kevin M ^c   Ye, Jianqin ^d   Santiago Ortiz, Jorge L ^e   Jackson, Wesley M ^a   Stahl, Andreas ^c   Schaffer, David V ^a,e   Yeghiazarians, Yerem ^d,f   Healy, Kevin E ^a,b  

^a University of California at Berkeley   (United States)

^b Lawrence Berkeley National Laboratory   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Growth factor sequestration; Heparin; Hyaluronic acid hydrogel; Neovascularization; Stem cell transplantation; TGF 1

Indexed keywords

BIOMECHANICS; BLOOD; BLOOD VESSELS; CYTOLOGY; DENSITY (SPECIFIC GRAVITY); ENDOTHELIAL CELLS; HYALURONIC ACID; HYDROGELS; ORGANIC ACIDS;

GROWTH FACTOR; HEPARIN; HYALURONIC ACID HYDROGELS; NEO-VASCULARIZATION; STEM CELL TRANSPLANTATION;

STEM CELLS;

ANGIOGENIC FACTOR; HEPARIN; HYALURONIC ACID; STEM CELL ANTIGEN 1; TRANSFORMING GROWTH FACTOR BETA1; BIOMATERIAL; HYDROGEL; PEPTIDE; SIGNAL PEPTIDE; THIOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIAC STEM CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENGRAFTMENT; HYDROGEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; ANIMAL; BINDING SITE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; MECHANICAL STRESS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); STEM CELL;

HYA; MURINAE;

ANIMALS; BINDING SITES; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HEPARIN; HYALURONIC ACID; HYDROGELS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; STEM CELL TRANSPLANTATION; STEM CELLS; STRESS, MECHANICAL; SULFHYDRYL COMPOUNDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84922803124     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.12.043     Document Type: Article

References (60)

1. Min J.-Y., Sullivan M.F., Yang Y., Zhang J.-P., Converso K.L., Morgan J.P., et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in post-infarcted pigs. Ann Thorac Surg 2002, 74:1568-1575.
2. Matsuura K., Honda A., Nagai T., Fukushima N., Iwanaga K., Tokunaga M., et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. JClin Investig 2009, 119:2204-2217.
3. Mizuno Y., Chang H., Umeda K., Niwa A., Iwasa T., Awaya T., et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB 2010, 24:2245-2253.
4. Liu H., Kim Y., Sharkis S., Marchionni L., Jang Y.Y. Invivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Transl Med 2011, 3. 82ra39.
5. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
6. Beauchamp J.R., Morgan J.E., Pagel C.N., Partridge T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. JCell Biol 1999, 144:1113-1122.
7. Mitkari B., Kerkela E., Nystedt J., Korhonen M., Mikkonen V., Huhtala T., et al. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Exp Neurol 2013, 239:158-162.
8. Mora-Lee S., Sirerol-Piquer M.S., Gutierrez-Perez M., Gomez-Pinedo U., Roobrouck V.D., Lopez T., et al. Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One 2012, 7:e43683.
9. Li Z., Wu J.C., Sheikh A.Y., Kraft D., Cao F., Xie X., et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 2007, 116:I46-I54.
10. Ye J., Boyle A., Shih H., Sievers R.E., Zhang Y., Prasad M., et al. Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury. PLoS One 2012, 7:e30329.
11. Horie N., Pereira M.P., Niizuma K., Sun G., Keren-Gill H., Encarnacion A., et al. Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 2011, 29:274-285.
12. Mureli S., Gans C.P., Bare D.J., Geenen D.L., Kumar N.M., Banach K. Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling. Am J Physiol Heart Circ Physiol 2013, 304:H600-H609.
13. Prestwich G.D. Engineering a clinically-useful matrix for cell therapy. Organogenesis 2008, 4:42-47.
14. Prestwich G.D. Delivery, retention and engraftment of progenitor cells in cell therapy. Biomatter 2013, 3. pii: e24549.
15. Prestwich G.D., Erickson I.E., Zarembinski T.I., West M., Tew W.P. The translational imperative: making cell therapy simple and effective. Acta Biomater 2012, 8:4200-4207.
16. Gao J., Liu R., Wu J., Liu Z., Li J., Zhou J., et al. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury. Biomaterials 2012, 33:3673-3681.
17. Lesman A., Habib M., Caspi O., Gepstein A., Arbel G., Levenberg S., et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A 2010, 16:115-125.
18. Parisi-Amon A., Mulyasasmita W., Chung C., Heilshorn S.C. Protein-engineered injectable hydrogel to improve retention of transplanted adipose-derived stem cells. Adv Healthc Mater 2013, 2:428-432.
19. Xiong Q., Hill K.L., Li Q., Suntharalingam P., Mansoor A., Wang X., et al. Afibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells 2011, 29:367-375.
20. Unterman S.A., Gibson M., Lee J.H., Crist J., Chansakul T., Yang E.C., et al. Hyaluronic acid-binding scaffold for articular cartilage repair. Tissue Eng Part A 2012, 18:2497-2506.
21. Wall S.T., Yeh C.C., Tu R.Y., Mann M.J., Healy K.E. Biomimetic matrices for myocardial stabilization and stem cell transplantation. JBiomed Mater Res A 2010, 95:1055-1066.
22. Kim J., Kim I.S., Cho T.H., Lee K.B., Hwang S.J., Tae G., et al. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 2007, 28:1830-1837.
23. Freudenberg U., Hermann A., Welzel P.B., Stirl K., Schwarz S.C., Grimmer M., et al. Astar-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials 2009, 30:5049-5060.
24. Khetan S., Katz J.S., Burdick J.A. Sequential crosslinking to control cellular spreading in 3-dimensional hydrogels. Soft Matter 2009, 5:1601-1606.
25. Raeber G.P., Lutolf M.P., Hubbell J.A. Molecularly engineered peg hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 2005, 89:1374-1388.
26. Craig E.A., Parker P., Austin A.F., Barnett J.V., Camenisch T.D. Involvement of the MEKK1 signaling pathway in the regulation of epicardial cell behavior by hyaluronan. Cell Signal 2010, 22:968-976.
27. Sakiyama-Elbert S.E., Hubbell J.A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. JControl Release 2000, 69:149-158.
28. Pike D.B., Cai S., Pomraning K.R., Firpo M.A., Fisher R.J., Shu X.Z., et al. Heparin-regulated release of growth factors invitro and angiogenic response invivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006, 27:5242-5251.
29. Sakiyama-Elbert S.E., Hubbell J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. JControl Release 2000, 65:389-402.
30. Cai S., Liu Y., Zheng Shu X., Prestwich G.D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005, 26:6054-6067.
31. Yang J., Watkins D., Chen C.-L., Bhushan B., Zhou Y., Besner G.E. Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis. JAm Coll Surg 2012, 215:534-545.
32. Prokoph S., Chavakis E., Levental K.R., Zieris A., Freudenberg U., Dimmeler S., et al. Sustained delivery of SDF-1alpha from heparin-based hydrogels to attract circulating pro-angiogenic cells. Biomaterials 2012, 33:4792-4800.
33. Guan K., Hasenfuss G. Cardiac resident progenitor cells: evidence and functional significance. Eur Heart J 2012, 34:2784-2787.
34. Jha A.K., Hule R.A., Jiao T., Teller S.S., Clifton R.J., Duncan R.L., et al. Structural analysis and mechanical characterization of hyaluronic acid-based doubly cross-linked networks. Macromolecules 2009, 42:537-546.
35. Jha A.K., Malik M.S., Farach-Carson M.C., Duncan R.L., Jia X. Hierarchically structured, hyaluronic acid-based hydrogel matrices via the covalent integration of microgels into macroscopic networks. Soft Matter 2010, 6:5045-5055.
36. Tae G., Kim Y.-J., Choi W.-I., Kim M., Stayton P.S., Hoffman A.S. Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules. Biomacromolecules 2007, 8:1979-1986.
37. Chung E.H., Gilbert M., Virdi A.S., Sena K., Sumner D.R., Healy K.E. Biomimetic artificial ECMs stimulate bone regeneration. JBiomed Mater Res A 2006, 79:815-826.
38. Voytik-Harbin S., Brightman A., Waisner B., Lamar C., Badylak S. Application and evaluation of the alamarblue assay for cell growth and survival of fibroblasts. Vitro Cell Dev Biol Anim 1998, 34:239-246.
39. Al-Nasiry S., Geusens N., Hanssens M., Luyten C., Pijnenborg R. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 2007, 22:1304-1309.
40. Yang L., Yang H., Rideout K., Cho T., Joo K.I., Ziegler L., et al. Engineered lentivector targeting of dendritic cells for invivo immunization. Nat Biotechnol 2008, 26:326-334.
41. Rezania A., Thomas C.H., Branger A.B., Waters C.M., Healy K.E. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. JBiomed Mater Res 1997, 37:9-19.
42. Lei Y., Gojgini S., Lam J., Segura T. The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels. Biomaterials 2011, 32:39-47.
43. Goumans M.-J., Liu Z., ten Dijke P. TGF-[beta] signaling in vascular biology and dysfunction. Cell Res 2009, 19:116-127.
44. Goumans M.-J., de Boer T.P., Smits A.M., van Laake L.W., van Vliet P., Metz C.H.G., et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes invitro. Stem Cell Res 2008, 1:138-149.
45. Bein K., Odell-Fiddler E.T., Drinane M. Role of TGF-beta1 and JNK signaling in capillary tube patterning. Am J Physiol Cell Physiol. 2004, 287:C1012-C1022.
46. Dantuma N.P., Lindsten K. Stressing the ubiquitin-proteasome system. Cardiovasc Res 2010, 85:263-271.
47. Workman P., Davies F.E. Astressful life (or death): combinatorial proteotoxic approaches to cancer-selective therapeutic vulnerability. Oncotarget 2011, 2:277-280.
48. Liu Z., Wang H., Wang Y., Lin Q., Yao A., Cao F., et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials 2012, 33:3093-3106.
49. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005, 97:512-523.
50. You W.-K., Yotsumoto F., Sakimura K., Adams R., Stallcup W. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function. Angiogenesis 2013, 17:61-76.
51. Hanjaya-Putra D., Bose V., Shen Y.-I., Yee J., Khetan S., Fox-Talbot K., et al. Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood 2011, 118:804-815.
52. Kusuma S., Shen Y.-I., Hanjaya-Putra D., Mali P., Cheng L., Gerecht S. Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix. Proc Natl Acad Sci 2013, 110:12601-12606.
53. Fujita M., Ishihara M., Simizu M., Obara K., Ishizuka T., Saito Y., et al. Vascularization invivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 2004, 25:699-706.
54. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Muller R., et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003, 21:513-518.
55. Kraehenbuehl T.P., Zammaretti P., Van der Vlies A.J., Schoenmakers R.G., Lutolf M.P., Jaconi M.E., et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials 2008, 29:2757-2766.
56. Bratt-Leal A.M., Nguyen A.H., Hammersmith K.A., Singh A., McDevitt T.C. Amicroparticle approach to morphogen delivery within pluripotent stem cell aggregates. Biomaterials 2013, 34:7227-7235.
57. Hudalla G.A., Koepsel J.T., Murphy W.L. Surfaces that sequester serum-borne heparin amplify growth factor activity. Adv Mater 2011, 23:5415-5418.
58. Wood M.D., MacEwan M.R., French A.R., Moore A.M., Hunter D.A., Mackinnon S.E., et al. Fibrin matrices with affinity-based delivery systems and neurotrophic factors promote functional nerve regeneration. Biotechnol Bioeng 2010, 106:970-979.
59. Wood M.D., Moore A.M., Hunter D.A., Tuffaha S., Borschel G.H., Mackinnon S.E., et al. Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration. Acta Biomater 2009, 5:959-968.
60. Martino M.M., Briquez P.S., Ranga A., Lutolf M.P., Hubbell J.A. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U. S. A 2013, 110:4563-4568.